Escitalopram Treatment of Night Eating Syndrome: a Randomized Controlled Trial.

Trial Profile

Escitalopram Treatment of Night Eating Syndrome: a Randomized Controlled Trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jul 2016

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Eating disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Jul 2012 Status changed from active, no longer recruiting to completed as reporeted by ClinicalTrials.gov record.
    • 05 Oct 2011 Results presented at the 2011 Annual Meeting of the North American Association for the Study of Obesity.
    • 21 Sep 2010 Planned end date changed from 1 Sep 2009 to 1 Aug 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top